2X1
Abivax SA · SWB:2X1
74.60 EUR−0.7000 −0.93%
Abivax SA (SWB:2X1) last traded at 74.60 EUR, down 0.93% on the day. Over the past year the stock is down 16.27%. Its 52-week range is 61.15 to 138.90. It is in the Health Technology sector (Pharmaceuticals: Other).
Key statistics
Open74.85
Day range74.60 – 74.90
52-week range61.15 – 138.90
Volume0
Average volume (10 days)428
Market cap (USD)7.74 B
EPS (TTM) (USD)−5.98
Dividend yield0.00%
Beta (1 year)1.66
Revenue (TTM) (USD)0
Employees69
Performance
−3.31%1 week
−11.87%1 month
−31.18%3 months
−30.60%6 months
−36.89%Year to date
−16.27%1 year
Technical reading
Strongly bearish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Abivax to Participate in Upcoming Fall Investor ConferencesEQS · 02 Nov 2026
- Abivax to Participate in Upcoming Fall Investor ConferencesGlobeNewswire · 02 Nov 2026
- Abivax Price Target Cut to $96.00/Share From $118.00 by WedbushDow Jones Newswires · 21 Oct 2026
- Abivax Price Target Maintained With a $175.00/Share by GuggenheimDow Jones Newswires · 20 Oct 2026
- Cedar Grove Capital Q3: Adds Zedcor, Auxly; exits MTY, ClearPointSeeking Alpha · 15 Oct 2026
- Seeking Alpha’s Quant Spotlight: Highest and lowest rated healthcare stocks ahead of Q3Seeking Alpha · 13 Oct 2026
- Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026EQS · 30 Sep 2026
- Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026GlobeNewswire · 30 Sep 2026
Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.